Lucira Health, Inc. (LHDX) Social Stream
LUCIRA HEALTH INC (LHDX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LHDX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 22 months, LHDX's average price target has gone down $26.75.
Over the past 43 weeks, LHDX's average upside potential has been 216.69%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
LHDX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
LHDX's average broker recommendation rating worsened by 0.17 over the prior 20 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LHDX as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, LUCIRA HEALTH INC's upside potential (average analyst target price relative to current price) is higher than 987.07% of them.
- In terms of how LUCIRA HEALTH INC fares relative to all US stocks, note that its average analyst price target is greater than 40.3% of that group.
- In the context of Healthcare stocks, LUCIRA HEALTH INC's number of analysts covering the stock is higher than 89.18% of them.
- LHDX has a lower variance in analysts' estimates than -250.82% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LUCIRA HEALTH INC are TKNO, KROS, and IMRA.
View All Top Stocks by Price Target
What is the outlook for LHDX? Use POWR Ratings for clearer insight into price direction.